APA (7th ed.) Citation

SY, M., S, K., SM, K., BC, J., CS, S., YM, C., . . . SH, K. (2005). Clinical efficacy of the gonadotropin-releasing hormone antagonist, ganirelix, in Korean women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer with recombinant follicle-stimulating hormone. Journal of Obstetrics & Gynaecology Research, 31(3), 227. https://doi.org/10.1111/j.1447-0756.2005.00277.x

Chicago Style (17th ed.) Citation

SY, Moon, Ku S, Kim SM, Jee BC, Suh CS, Choi YM, Kim JG, and Kim SH. "Clinical Efficacy of the Gonadotropin-releasing Hormone Antagonist, Ganirelix, in Korean Women Undergoing Controlled Ovarian Hyperstimulation for in Vitro Fertilization and Embryo Transfer with Recombinant Follicle-stimulating Hormone." Journal of Obstetrics & Gynaecology Research 31, no. 3 (2005): 227. https://doi.org/10.1111/j.1447-0756.2005.00277.x.

MLA (9th ed.) Citation

SY, Moon, et al. "Clinical Efficacy of the Gonadotropin-releasing Hormone Antagonist, Ganirelix, in Korean Women Undergoing Controlled Ovarian Hyperstimulation for in Vitro Fertilization and Embryo Transfer with Recombinant Follicle-stimulating Hormone." Journal of Obstetrics & Gynaecology Research, vol. 31, no. 3, 2005, p. 227, https://doi.org/10.1111/j.1447-0756.2005.00277.x.